Neuroinflammation: The Silent Driver of Alzheimer’s Pathology

Neuroinflammation has increasingly been recognized as a major factor in Alzheimer’s disease progression. This session will explore how immune system dysfunction, particularly the role of microglia and astrocytes, contributes to neuroinflammation and the pathogenesis of dementia. It will examine how targeting neuroinflammation offers a potential therapeutic pathway for slowing or halting disease progression, with a focus on new anti-inflammatory therapies under development.
 

    Related Conference of Neuroinflammation: The Silent Driver of Alzheimer’s Pathology

    September 23-24, 2026

    6th Annual Congress on Mental Health

    Amsterdam, Netherlands
    October 19-20, 2026

    6thAnnual Congress on Mental Health & Psychiatry

    Paris, France
    October 26-27, 2026

    6th Annual Psychiatrists and Psychologists Meet

    Amsterdam, Netherlands
    October 26-27, 2026

    International Congress on Cognitive Psychotherapy

    Amsterdam, Netherlands
    January 28-29, 2027

    9th International Congress on Mental Health

    Singapore City, Singapore
    March 18-19, 2027

    34th World Psychiatrists and Psychologists Meet

    Berlin, Germany
    March 25-26, 2027

    8th Annual Congress on Psychiatry

    Paris, France
    May 19-20, 2027

    9th European Autism Congress

    Paris, France
    September 14-15, 2027

    5th World Congress on Psychiatry

    London, UK

    Neuroinflammation: The Silent Driver of Alzheimer’s Pathology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in